The ESMO Targeted Anticancer Therapies (TAT) Congress 2025 is dedicated to targeted agents for the treatment of cancer and includes topics such as:
- Clinical studies
- Biomarkers
- Drug development methodology
- Drug design
- Immuno-oncology clinical studies
- Genomics and proteomics
- New immunological targets
- Molecular profiling and diagnosis
- Phase 1 studies
- Preclinical drug profiling
- Targeted drug delivery
- Preclinical test models
- Vaccines
- Translational studies
- New molecular targets
Who should Attend
Delegates from industry, academia and governmental agencies with an interest in the development of innovative cancer therapies.
